To include your compound in the COVID-19 Resource Center, submit it here.

Onsenal celecoxib regulatory update

The European Commission (EC) withdrew marketing authorization for Onsenal celecoxib from Pfizer to reduce the

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE